Theodoros Roumeliotis

27PUBLICATIONS
196CO-AUTHORS
Molecular targetsHaematological tumoursMolecular, biological, and multi-scale communicationsBiomedical instrumentationCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Sep 22, 2026
The anion channel GPR89 is a tumor-specific dependency in breast cancer.

|Aug 12, 2026
RNA terminal uridylyl transferases are druggable vulnerabilities in AML but are dispensable for normal hematopoiesis.

|Apr 25, 2026
Cryo-EM structures of the CDK11-cyclin L-SAP30BP complex reveal mechanisms of CDK11 regulation.

|Feb 18, 2026
LOX Inhibition Disrupts a Collagen-Integrin-MYC Axis to Suppress Progression of Invasive Lobular Carcinoma.

Renée L Flaherty, Flavia Hughes, George Sflomos

|Feb 02, 2026
UltraPlex-TMT: Expanding Isobaric Hyperplexing via Orthogonal Protease Cleavage.

Theodoros I Roumeliotis, Fernando J Sialana, Jenny Ho

|Jan 12, 2026
Unhooking the Hook: Optimization of the Aurora A Targeting PROTAC JB170 to CCT400028, an In Vitro Degrader Chemical Probe.

Jack A O'Hanlon, Katrin Gutsche, Juliane Elisabeth Müller

Pageof 5

Frequent Collaborators

22 joint publications

Jyoti Sharma Choudhary

5 joint publications

Syed Haider

5 joint publications

Christopher J Lord

3 joint publications

Dragomir Krastev